David Larsen
Stock Analyst at BTIG
(2.13)
# 2,888
Out of 5,138 analysts
93
Total ratings
39.47%
Success rate
-2.1%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDLN Medline | Initiates: Buy | $50 | $44.12 | +13.33% | 1 | Jan 12, 2026 | |
| BTSG BrightSpring Health Services | Maintains: Buy | $41 → $50 | $39.20 | +27.55% | 4 | Dec 23, 2025 | |
| SLP Simulations Plus | Downgrades: Neutral | n/a | $20.33 | - | 4 | Dec 18, 2025 | |
| LFST LifeStance Health Group | Maintains: Buy | $9 → $10 | $7.25 | +37.93% | 2 | Dec 12, 2025 | |
| PIII P3 Health Partners | Suspends: Neutral | n/a | $3.20 | - | 3 | Dec 12, 2025 | |
| AGL agilon health | Suspends: Neutral | n/a | $1.02 | - | 2 | Dec 12, 2025 | |
| HQY HealthEquity | Reiterates: Buy | $130 | $85.37 | +52.28% | 5 | Dec 4, 2025 | |
| VEEV Veeva Systems | Reiterates: Buy | $340 | $222.21 | +53.01% | 4 | Nov 21, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $10 | $3.77 | +165.25% | 4 | Nov 18, 2025 | |
| EVH Evolent Health | Maintains: Buy | $20 → $16 | $3.77 | +324.40% | 7 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $50 → $45 | $26.95 | +66.98% | 2 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $85 | $31.38 | +170.87% | 2 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.35 | +108.96% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $11.04 | +35.87% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $2.31 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $80 | $41.26 | +93.89% | 2 | Jun 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $28 | $24.52 | +14.19% | 4 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $31 | $21.95 | +41.23% | 3 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $237.68 | +9.39% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $2.40 | +191.67% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.83 | +741.25% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $50.55 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $23.33 | +50.02% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $6.28 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $4.71 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $212.45 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $840.46 | -80.96% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $79.98 | - | 5 | Apr 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $78.60 | +8.14% | 3 | Feb 9, 2018 |
Medline
Jan 12, 2026
Initiates: Buy
Price Target: $50
Current: $44.12
Upside: +13.33%
BrightSpring Health Services
Dec 23, 2025
Maintains: Buy
Price Target: $41 → $50
Current: $39.20
Upside: +27.55%
Simulations Plus
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $20.33
Upside: -
LifeStance Health Group
Dec 12, 2025
Maintains: Buy
Price Target: $9 → $10
Current: $7.25
Upside: +37.93%
P3 Health Partners
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $3.20
Upside: -
agilon health
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $1.02
Upside: -
HealthEquity
Dec 4, 2025
Reiterates: Buy
Price Target: $130
Current: $85.37
Upside: +52.28%
Veeva Systems
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $222.21
Upside: +53.01%
LifeMD
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $10
Current: $3.77
Upside: +165.25%
Evolent Health
Nov 7, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $3.77
Upside: +324.40%
Nov 7, 2025
Maintains: Buy
Price Target: $50 → $45
Current: $26.95
Upside: +66.98%
Nov 4, 2025
Reiterates: Buy
Price Target: $85
Current: $31.38
Upside: +170.87%
Oct 21, 2025
Reiterates: Buy
Price Target: $7
Current: $3.35
Upside: +108.96%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $11.04
Upside: +35.87%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $2.31
Upside: -
Jun 2, 2025
Upgrades: Buy
Price Target: $80
Current: $41.26
Upside: +93.89%
Mar 31, 2025
Upgrades: Buy
Price Target: $28
Current: $24.52
Upside: +14.19%
Nov 11, 2024
Maintains: Buy
Price Target: $30 → $31
Current: $21.95
Upside: +41.23%
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $237.68
Upside: +9.39%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $2.40
Upside: +191.67%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.83
Upside: +741.25%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $50.55
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $23.33
Upside: +50.02%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $6.28
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $4.71
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $212.45
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $840.46
Upside: -80.96%
Apr 4, 2018
Upgrades: Outperform
Price Target: n/a
Current: $79.98
Upside: -
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $78.60
Upside: +8.14%